| [1] |
GE Dan, WANG Zhi, DING Qun, GUO Tonglan, XU Tongdao.
Relationship between Remnant Cholesterol and Non-alcoholic Fatty Liver Disease as well as Progressive Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2026, 29(20): 2854-2859.
|
| [2] |
MAO Ruixiao, FENG Zhenzhen, LIU Wenrui, WANG Jiajia, LI Jiansheng.
Analysis of the Temporal and Spatial Evolution of TCM Syndromes in Idiopathic Pulmonary Fibrosis in the Past 30 Years
[J]. Chinese General Practice, 2026, 29(19): 2678-2687.
|
| [3] |
ZHANG Mingyue, HOU Yan.
Research Progress of Exhaled Nitric Oxide and Alveolar Nitric Oxide in Interstitial Lung Diseases
[J]. Chinese General Practice, 2026, 29(18): 2571-2576.
|
| [4] |
HUANG Ying, ZHOU Zhiyuan, PAN Zhixiong, ZHU Qun.
Advances in the Association between Metabolic Dysfunction-associated Steatotic Liver Disease, Type 2 Diabetes Mellitus and Cardiovascular Complications
[J]. Chinese General Practice, 2026, 29(09): 1212-1216.
|
| [5] |
FAN Xueming, YANG Ningning, ZHENG Zheng, WU Yumei, WANG Qi.
Analysis of Correlation Factors and Predictive Value of Microvascular Complications in Patients with Type 2 Diabetes Mellitus Combined with Metabolic-associated Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(36): 4578-4585.
|
| [6] |
YANG Qifen, ZHAO Huiliang, GUO Yongsheng, QU Jinglian.
The Impact of the Jagged1/Notch1 Signalling Pathway on Endothelial-mesenchymal Transition in Idiopathic Pulmonary Fibrosis
[J]. Chinese General Practice, 2025, 28(25): 3151-3160.
|
| [7] |
HAN Bing, DU Shuzhen, MENG Xiaoxue, ZHANG Lu, CHEN Zixian, TENG Fengling.
Plasma Periostin Levels Correlated with Myocardial Fibrosis in Patients with Heart Failure with Different Ejection Fraction
[J]. Chinese General Practice, 2025, 28(24): 2979-2984.
|
| [8] |
WU Sha, ZHANG Daiyi, LI Jin, XUAN Qinkao, QIAN Xiaodong, ZHU Chuanwu, PU Jianhong, ZHU Li.
Correlation Analysis and Model Construction of Metabolic Associated Fatty Liver Disease and Hyperglycemia Based on a Health Examination Cohort
[J]. Chinese General Practice, 2025, 28(23): 2861-2869.
|
| [9] |
SHEN Mingmei, LYU Yujiao, ZHANG Shangbo, ZHOU Xinchen, DONG Shuhan, ZHANG Zhuo, LIU Yongchao.
Calcium Sensitive Receptors Mediate Signaling Pathways in Myocardial Injury
[J]. Chinese General Practice, 2025, 28(18): 2301-2306.
|
| [10] |
ZHU Ziyi, HE Guixin, QIN Weibin, SONG Hui, ZHANG Liwen, TANG Weizhi, YANG Feifei, LIU Lingyun, OUYANG Bin.
Research Progress of Mitochondrial Autophagy in Improving Myocardial Fibrosis after Myocardial Infarction and Intervention of Traditional Chinese Medicine
[J]. Chinese General Practice, 2025, 28(18): 2294-2300.
|
| [11] |
NIE Yuanyuan, FANG Da, XU Hao, YANG Donghui, BI Yan, GU Tianwei.
Clinical Characteristics and Cardiovascular Disease Risk of Type 2 Diabetes Populations with Different Liver Fibrosis Risks
[J]. Chinese General Practice, 2025, 28(15): 1847-1854.
|
| [12] |
TAN Huihui, MAO Wei, YANG Zihan.
Research Progress of Annexin A1 in Respiratory Diseases
[J]. Chinese General Practice, 2025, 28(13): 1668-1673.
|
| [13] |
ZHUO Lili, QU Huanjia, ZHANG Qiuling.
The Effect of Type 2 Diabetes Mellitus and Obesity on FIB-4 Index Screening for Early Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(11): 1354-1360.
|
| [14] |
HUANG Lihui, SHU Juan, TAO Huihui, BAO Hairong.
Progress in Treatment of Post Inflammatory Pulmonary Fibrosis Induced by SARS-CoV-2 Infection
[J]. Chinese General Practice, 2024, 27(32): 4085-4092.
|
| [15] |
REN Lingxuan, LU Ziqi, QI Wei, FENG Zhijie.
Functional Analysis of Macrophages in the Progression of Liver Cirrhosis and Liver Cancer
[J]. Chinese General Practice, 2024, 27(29): 3654-3663.
|